Statement on Slavery and Human Trafficking
Genedrive fully endorses the Modern Slavery Act 2015 in order to eliminate all forms of human slavery, human trafficking and forced labour (“Modern Slavery”) and it endeavours to ensure both its employees and business partners understand the importance of complying with the act.
Genedrive is a publicly listed pharmacogenetics company focusing on creating innovative point of care genetic tests to improve health and support the correct use of medicines.
We have over 40 employees based either in its office in Manchester or out in the field.
All employees at Genedrive are trained on the company code of conduct which covers topics such as Human Rights.
Our activities are overseen by the Board of Directors who have overall and ultimate responsibility for Genedrive’s activities. Genedrive’s day to day management resides in our Executive Team which reports directly to the Board of Directors.
Our supply chains
Genedrive requires its business partners to comply with all applicable laws, regulations, industry codes and contractual terms as well as with generally accepted sustainability standards.
Ethics: Suppliers shall conduct their business in an ethical manner and act with integrity.
Human Rights and Labour: Suppliers shall be committed to upholding the human rights of workers and treat them with dignity and respect.
Health and Safety: Suppliers shall provide a safe and healthy working environment.
Environment: Suppliers shall operate in an environmentally responsible and efficient manner, and they shall minimise adverse impacts on the environment.
Genedrive believes that because of the steps it has taken, it has a low risk of modern slavery issues within the business and in its direct supply chain, and there have been no reported instances of suspected modern slavery or people trafficking during the year. However, we are not complacent and will continue to be alert for potential issues.
We are committed to minimising the risk of modern slavery and human trafficking occurring in our organisation and supply chains and will: (i) continue to review our approach to modern slavery and human trafficking and raise awareness across the organisation; (ii) continue to refine our third-party risk management and due diligence processes; and (iii) revise and refine our procurement procedures.
Approval for this statement
This statement is made pursuant to section 54 of the Modern Slavery Act 2015 and constitutes our slavery and human trafficking statement for the financial period ending 30 June 2023. It has been approved by the Board of Directors.
Chief Executive Officer
20th December 2023